Enoxaparin-Induced Liver Injury: Case Report and Review of the Literature and FDA Adverse Event Reporting System (FAERS)

Anticoagulants are a well known cause of drug-induced liver injury (DILI). We recently encountered a 45-year-old male who developed DILI during treatment with enoxaparin, a low-molecular-weight heparin (LMWH), for dural venous thrombosis. The man received enoxaparin 80 mg subcutaneously, twice daily...

Descripción completa

Detalles Bibliográficos
Autores principales: Hahn, Katherine J., Morales, Shannon J., Lewis, James H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2015
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5005670/
https://www.ncbi.nlm.nih.gov/pubmed/27747729
http://dx.doi.org/10.1007/s40800-015-0018-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5005670/
https://www.ncbi.nlm.nih.gov/pubmed/27747729
http://dx.doi.org/10.1007/s40800-015-0018-0

Ejemplares similares